Metastasis-directed Therapy in the Management of Urothelial Carcinoma: A Systematic Review and Meta-analysis.
In this prospectively registered meta-analysis (PROSPERO: CRD42024501283), we pooled data on patients treated with metastasis-directed therapies (MDTs) for metastatic urothelial cancer (mUC). On January 24, 2024, we searched PubMed (MEDLINE), Scopus, and …